Regarding the mechanism of how PPARδ ameliorates cardiac fibrosis, a previous study indicated that the PPARβ/δ agonist inhibited STAT3 activation and insulin resistance in human liver cells [17]. The gene discussed is STAT3; the disease is Insulin resistance.